|
HS Code |
165556 |
| Product Name | Fmoc-Trp-OPfp |
| Full Name | N-9-Fluorenylmethyloxycarbonyl-L-tryptophan pentafluorophenyl ester |
| Chemical Formula | C32H20F5N2O5 |
| Cas Number | 141624-46-6 |
| Appearance | white to off-white powder |
| Purity | ≥98% |
| Storage Temperature | 2-8°C |
| Solubility | soluble in DMF and DCM |
| Application | peptide synthesis |
| Protecting Group | Fmoc |
| Activation Group | Pentafluorophenyl (OPfp) |
| Amino Acid Type | L-tryptophan |
| Handling | use under dry and inert conditions |
| Shelf Life | 12 months under recommended storage |
As an accredited Fmoc-Trp-OPfp factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging for Fmoc-Trp-OPfp contains 1 gram in an amber glass vial, sealed, with labeled product name, purity, and warnings. |
| Shipping | Fmoc-Trp-OPfp is shipped in a tightly sealed container, protected from light and moisture to ensure stability and purity. The chemical is packed according to regulatory standards for hazardous materials, often with cooling packs if required. Accompanying safety documentation (SDS) is included. Handle with appropriate personal protective equipment upon receipt. |
| Storage | **Fmoc-Trp-OPfp** should be stored in a tightly sealed container, under a dry, inert atmosphere (such as nitrogen or argon), and protected from light. Ideally, it should be kept at –20 °C to preserve stability. Avoid moisture and exposure to air, as the compound is sensitive to hydrolysis and oxidation. Store separately from acids, bases, and incompatible materials. |
Applications of Fmoc-Trp-OPfp in Industrial ManufacturingFmoc-Trp-OPfp serves as an advanced peptide synthesis intermediate, supporting precise and high-yield production for various industrial sectors. We manufacture this material for demanding downstream uses where specification compliance, process reliability, and traceability are essential across pharmaceutical, biotechnology, diagnostics, and research applications. 1. Solid-Phase Peptide Synthesis (SPPS) for Pharmaceutical ActivesMajor pharmaceutical peptide manufacturers apply Fmoc-Trp-OPfp as a key protected amino acid in the assembly of complex peptide APIs, including hormone analogues, therapeutic peptides, and polypeptide-based drugs produced via SPPS protocols. Our technical team supports integration into automated synthesizer cycles, where the reagent enables efficient Fmoc-based coupling during elongation sequences. Consistent product quality supports scalable batch manufacturing in regulated drug substance plants. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Custom Peptide Synthesis for Diagnostic ReagentsIndustrial diagnostic kit suppliers utilize Fmoc-Trp-OPfp to build high-purity peptide antigens and capture molecules required in immunoassays, enzyme-linked immunosorbent assay (ELISA) standards, and lateral flow devices. The coupling agent ensures reliably protected tryptophan residues in immunoreactive peptides, critical for batch reproducibility and assay accuracy. In-process controls during synthesis support traceable quality for regulated diagnostics. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Peptide-Based Research Tools for Biotechnology R&DBiotechnology institutes and research tool suppliers incorporate our Fmoc-protected tryptophan derivative within oligopeptide synthesis for cell signaling, structural biology, and receptor binding studies. Strict batch-to-batch performance ensures uninterrupted research workflows and reliable scale-up from milligram to multi-gram quantities in academic, contract, and commercial laboratories. Fmoc-Trp-OPfp addresses the need for controlled aromatic side-chain integrity in structure-activity studies. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. GMP Peptide Manufacturing for Injectable Drug ProductscGMP-certified peptide manufacturing sites employ Fmoc-Trp-OPfp under validated production conditions for the assembly of high-purity injectable drug substances. Its performance supports stringent requirements for impurity profiles, lot reproducibility, and regulatory documentation. Routine QC analysis, validated cleaning protocols, and batch records document each step where this protected amino acid enters the production stream for sterile injectables. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Fmoc-Trp-OPfp prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to sales7@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Years spent in peptide manufacturing teach a lot about consistency, reliability, and purity. In peptide synthesis, protecting groups and activated esters make all the difference—minimizing side reactions and maximizing yield—even in complex chains. Fmoc-Trp-OPfp makes a big impact here, where precision meets practical chemistry.
Many synthetic routes in research labs stop at the Fmoc-protected amino acid, but that is not always enough. Fmoc-Trp-OPfp, where tryptophan is protected with the fluorenylmethyloxycarbonyl group and activated as the pentafluorophenyl ester, pushes the process forward with greater efficiency. Chemists want to spend less time troubleshooting coupling steps and more time analyzing their actual product. With Fmoc-Trp-OPfp, everyone in the lab—whether exploring small research targets or scaling larger batches—can expect more streamlined assembly, particularly at the challenging tryptophan position.
What sets this compound apart is its structure: the Fmoc group protects the amino function, and the pentafluorophenyl ester activates the carboxyl terminus for rapid peptide bond formation. This structure avoids many of the headaches caused by other activating strategies. Carbodiimide coupling often leads to tough-to-remove urea byproducts; hydroxybenzotriazole-activated esters require careful handling due to safety risks. Pentafluorophenyl activation sidesteps these hurdles, delivering high conversion under relatively mild conditions. This isn’t just theoretical. Teams making peptides see the effects in cleaner HPLC profiles and higher crude purity after the first coupling step.
Every lot we produce undergoes rigorous in-house testing. Peptide synthesis leaves little room for impurities, especially with tryptophan. Its sensitive indole side chain can react with almost anything, leading to unwanted side-products. Using OPfp activation, the coupling proceeds without exposing the indole ring to harsh reagents or excessive heating. Dry solvents, low temperatures, and careful work-up steps become more manageable, since the compound itself brings so much reactivity to the table. This advantage translates into less work, lower costs from reduced purification demands, and an easier time scaling from milligrams to hundreds of grams.
We receive calls from researchers frustrated by inconsistent batches or unexplained variability in sensitive amino acid derivatives. Unfortunately, not all Fmoc-Trp-OPfp is created equal. Moisture, micro-scale impurities, and handling mistakes cause wide swings in coupling efficiency. That’s why we maintain strict environmental control, and all material gets sealed promptly to prevent hydrolysis. Our batches routinely meet or exceed peptide-grade standards. Purity alone is only one metric—batch-to-batch repeatability counts for much more. Our analytical protocols extend beyond HPLC purity and NMR spectra. We test for trace residuals that inhibit coupling and routinely check for stability during storage.
Some facilities source bulk starting materials from outside vendors and finish activation in-house, but this opens up unpredictable quality. Our process starts from raw amino acids we select and verify in our lab. The pentafluorophenol activation gets carried out in solvent systems proven to minimize hydrolysis and side reactions. We never ship product that does not match the same benchmarks we use for our own research peptide programs.
Fmoc-Trp-OPfp appears as a white to off-white powder. There’s a tendency among less experienced chemists to judge quality by color, but real reliability comes from purity and reactivity. Each batch shows sharp TLC and HPLC spots, and infra-red scans reveal no signal for moisture-laden byproducts. Specific rotation matches the natural L-amino acid. Melting points stay within a narrow range, evidence of a controlled crystallization process. We follow up batch QA with solid-phase and liquid-phase test couplings—direct proof that this compound holds up under real-world synthetic routes.
Fmoc-Trp-OPfp requires care in storage: tightly sealed under inert gas at low temperatures, protected from light and moisture. Small changes in humidity destroy the activated ester function. Gloves, clean glassware, and pre-dried solvents are not optional, especially at scale. We return to these basics in every consultation with partners seeking to optimize synthesis or move to automation.
Several other tryptophan derivatives attempt the same job in peptide chemistry. Fmoc-Trp-OH is readily available but requires separate activation during each coupling reaction, slowing down workflow and raising side-reaction risks. In contrast, Fmoc-Trp-OPfp brings the activated ester into the lab, reducing reagent prep and wasted time.
We also field questions on alternative activated esters—NHS-, HOBt- or HATU-based derivatives. Some chemists prefer them for specific protocols, but OPfp activation achieves higher yields with difficult peptide sequences that feature multiple hindered residues or require rapid coupling cycles. It’s especially valuable in difficult syntheses—cyclic peptides, branched sequences, or peptides incorporating several bulky or aromatic residues. With OPfp, side-product formation drops noticeably, and isolation becomes less labor-intensive.
For researchers concerned with hazardous byproducts, Fmoc-Trp-OPfp generates pentafluorophenol as its sole leaving group, simplifying post-reaction workup. Some competitors produce potentially explosive or highly toxic side products. In our own labs, cleaning up after OPfp-mediated reactions means shorter evaporation and extraction steps, directly saving hands-on time.
Robotic synthesizers have changed the way labs approach peptide assembly, but machine accuracy means little if building blocks cause jams or need reactivation. Fmoc-Trp-OPfp dissolves easily in the same solvents automated systems prefer, so chemists can load and run without constant monitoring or priming. This is not an abstract benefit. Setups handling dozens of sequences per week cannot afford slowdowns. Our own trials with standard protocols, and reports from core facilities, show less resin fouling and sharper purity readings when OPfp esters are part of the cycle.
This isn't just theory—we’ve produced hundreds of high-purity peptides on short timelines, with yields and mass balance confirmed across both short and long chains. Automated runs with poorly activated amino acids deliver lower yields and introduce carryover from insufficiently reactive esters. The experience: using Fmoc-Trp-OPfp in automated peptide synthesis reduces error, streamlines washing steps, and certainly cuts down end-to-end production time. Researchers scaling up peptide libraries for screening, SAR, or vaccine development appreciate this practical shortcut.
Peptide chemistry puts pressure on every partner in the supply chain. Impure or misactivated raw materials add noise to the process, slowing research and wasting funding. Often, delays trace back to small issues—a single batch where side-product content crept up, crystals absorbed too much moisture, or a subtle impurity poisoned the coupling. Our decades spent on in-house peptide manufacturing mean we attack these issues before they leave the factory.
Customer feedback here matters. When a researcher points out a change in TLC mobility, HPLC profile, or reactivity, we investigate and apply fixes. This feedback loop is built into our production. It’s not just about turning out acceptable powder. Each order comes with full analytical data, first-hand coupling data, and the chance to consult directly with experts who run these reactions daily. Many times, the questions we receive prompt us to refine protocols and implement better quality checks for future lots.
Clients in drug discovery or diagnostic development cannot afford ambiguity in their raw materials. A missed or low-yield coupling step snowballs into failed lots or repeated syntheses. Our Fmoc-Trp-OPfp is defined by its reliability in applications that count—screening libraries, lead optimization, and cGMP process development.
Difficult peptide projects call for high-purity, well-characterized building blocks. Tryptophan residues often introduce more risk than other amino acids, due to their large aromatic side chains and sensitivity to oxidation and acid. We select the best available L-tryptophan as the base, use controlled Fmoc and OPfp activation steps, and continually monitor crystallization and drying cycles. This attention to detail translates into a product that does not fall short in the lab.
Fmoc-Trp-OPfp enhances complex assembly sequences, like those with several consecutive hindered or aromatic amino acids. Without strong activation, coupling slows or stalls out, and the resulting peptide may contain unreacted residues, causing headaches all the way to prep HPLC. Our activated ester removes these barriers, supporting smoother synthesis of long, modified chains—all the way up to peptide-drug conjugates or sophisticated diagnostic reagents.
We keep batch sizes flexible, covering both the needs of university research labs and multi-kilogram industrial manufacturing lines. A small group making six-mers for basic studies needs easy-to-handle Fmoc-Trp-OPfp, available in manageable vial sizes. Commercial groups scaling up for pilot runs or early GMP production get larger, packed lots. In both cases, getting the right characteristics—flowability, low moisture, stable ester content—builds confidence along the supply chain.
For repeated peptide projects, such as those found in antibody epitope mapping or vaccine prototyping, lot-to-lot uniformity prevents research hiccups. Too many times, we’ve been approached to solve issues caused by inconsistent off-the-shelf suppliers. Our on-demand production capability means we scale up only after preliminary lots complete full QA and test couplings.
Speed in peptide assembly drives every modern program. Drug development timelines, diagnostic kit commercialization, and grant-driven academic projects all benefit from minimizing days lost to failed couplings or uncertain material quality. Fmoc-Trp-OPfp provides not only the right chemistry, but a supply solution that avoids long wait times, communication breakdowns, and last-minute shipping delays. Our job as a manufacturer centers around proactive communication, logistical planning, and robust production pipelines.
On the safety front, OPfp-activated esters, when handled correctly, generate predictable waste. We provide detailed guidance on handling, disposal, and recovery of pentafluorophenol. This keeps our partners' teams safe and avoids unwanted surprises in post-coupling workup.
Peptide manufacturers are always under pressure to deliver more complex, larger, and modified sequences. The tools and intermediates used must evolve in tandem. As research programs push into macrocycles, stapled peptides, or hybrid conjugates, unactivated or unreliable tryptophan derivatives no longer suffice. A building block like Fmoc-Trp-OPfp opens up workflows that allow for late-stage modifications and post-assembly derivatizations. Because OPfp activation is both strong and clean, chemists trust it not to introduce complications in downstream chemistry.
Feedback and collaboration drive these improvements. Insights gained from talking directly to bench chemists—whether in pharma, biotech, or academia—feed back into formulation tweaks, process adjustments, and support resources. We continue to invest in analytical instruments, process validation, and application research so our Fmoc-Trp-OPfp keeps pace with the most demanding projects.
Working at scale with Fmoc-Trp-OPfp allows us to refine not just the product, but also the delivery and support our partners rely on. This means rapid response to inquiries, clear documentation, same-day shipping on standard orders, and access to real chemists who troubleshoot problems from start to finish. We’ve handled every scenario, from rescuing stalled syntheses to troubleshooting unexpected impurities, and from designing custom synthesis plans to prepping kilogram batches for regulated production.
This level of involvement produces more than just chemical intermediates. It shapes the experience of every chemist using them. Fmoc-Trp-OPfp is more than a reagent on a shelf; it is the product of years refining practical protocols, solving real-world challenges, and demonstrating the true value of expertise behind every batch delivered.